162 related articles for article (PubMed ID: 27067681)
41. Postoperative Adjuvant Systemic Therapy in Completely Resected Non-Small-Cell Lung Cancer: A Systematic Review.
Bradbury P; Sivajohanathan D; Chan A; Kulkarni S; Ung Y; Ellis PM
Clin Lung Cancer; 2017 May; 18(3):259-273.e8. PubMed ID: 28162945
[TBL] [Abstract][Full Text] [Related]
42. Adjuvant therapy in early-stage non-small cell lung cancer.
Serke M
Front Radiat Ther Oncol; 2010; 42():135-144. PubMed ID: 19955799
[TBL] [Abstract][Full Text] [Related]
43. Role of adjuvant chemotherapy in NSCLC (stages I to III).
Coleman MH; Bueno R
Surg Oncol Clin N Am; 2011 Oct; 20(4):757-67. PubMed ID: 21986270
[TBL] [Abstract][Full Text] [Related]
44. Adjuvant chemotherapy for non-small cell lung cancer: contribution of the International Adjuvant Lung Trial.
Dunant A; Pignon JP; Le Chevalier T
Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5017s-5021s. PubMed ID: 16000606
[TBL] [Abstract][Full Text] [Related]
45. Advances in our understanding of postoperative adjuvant chemotherapy in resectable non-small-cell lung cancer.
Hotta K; Matsuo K; Kiura K; Ueoka H; Tanimoto M
Curr Opin Oncol; 2006 Mar; 18(2):144-50. PubMed ID: 16462183
[TBL] [Abstract][Full Text] [Related]
46. Adjuvant chemotherapy for non-small cell lung cancer: a New Zealand perspective.
Sasidharan R; Gibbs D; Sullivan R; Simpson A; Perez D; Christmas T; McKeage M
N Z Med J; 2006 Nov; 119(1245):U2310. PubMed ID: 17146485
[TBL] [Abstract][Full Text] [Related]
47. Adjuvant chemotherapy for non-small cell lung cancer.
Solomon B; Bunn PA
Cancer Invest; 2007 Jun; 25(4):217-25. PubMed ID: 17612931
[TBL] [Abstract][Full Text] [Related]
48. Use of adjuvant chemotherapy in non-small cell lung cancer in routine practice.
Massard C; Tran Ba Loc P; Haddad V; Pignon JP; Girard P; Monnet I; Trédaniel J; Besse B; Soria JC
J Thorac Oncol; 2009 Dec; 4(12):1504-10. PubMed ID: 19745763
[TBL] [Abstract][Full Text] [Related]
49. Alpha-actinin-4 (ACTN4) gene amplification is a predictive biomarker for adjuvant chemotherapy with tegafur/uracil in stage I lung adenocarcinomas.
Noro R; Honda K; Nagashima K; Motoi N; Kunugi S; Matsubayashi J; Takeuchi S; Shiraishi H; Okano T; Kashiro A; Meng X; Yoshida Y; Watanabe S; Usuda J; Inoue T; Wilber H; Ikeda N; Seike M; Gemma A; Kubota K
Cancer Sci; 2022 Mar; 113(3):1002-1009. PubMed ID: 34845792
[TBL] [Abstract][Full Text] [Related]
50. Efficacy of Adjuvant Chemotherapy With Tegafur-Uracil in Patients With Completely Resected, Node-Negative NSCLC-Real-World Data in the Era of Molecularly Targeted Agents and Immunotherapy.
Shukuya T; Takamochi K; Sakurai H; Yoh K; Hishida T; Tsuboi M; Goto Y; Kudo Y; Ohde Y; Okumura S; Taguri M; Kunitoh H
JTO Clin Res Rep; 2022 May; 3(5):100320. PubMed ID: 35601927
[TBL] [Abstract][Full Text] [Related]
51. Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial.
Waller D; Peake MD; Stephens RJ; Gower NH; Milroy R; Parmar MK; Rudd RM; Spiro SG
Eur J Cardiothorac Surg; 2004 Jul; 26(1):173-82. PubMed ID: 15200998
[TBL] [Abstract][Full Text] [Related]
52. Heat shock protein 70 as a predictive marker for platinum-based adjuvant chemotherapy in patients with resected non-small cell lung cancer.
Park TS; Kim HR; Koh JS; Jang SH; Hwang YI; Yoon HI; Chung JH; Kim CH; Kim SS; Kim WS; Jo J; Lee JC; Choi CM
Lung Cancer; 2014 Nov; 86(2):262-7. PubMed ID: 25261232
[TBL] [Abstract][Full Text] [Related]
53. Adjuvant Chemotherapy in Resected Stage II Non-small Cell Lung Cancer: Evaluating the Impact of Dose Intensity and Time to Treatment.
Ramsden K; Laskin J; Ho C
Clin Oncol (R Coll Radiol); 2015 Jul; 27(7):394-400. PubMed ID: 25800720
[TBL] [Abstract][Full Text] [Related]
54. Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
Bunn PA
Clin Lung Cancer; 2004 Sep; 6(2):85-98. PubMed ID: 15476594
[TBL] [Abstract][Full Text] [Related]
55. Postoperative adjuvant chemotherapy for stage I non-small cell lung cancer.
Park JH; Lee CT; Lee HW; Baek HJ; Zo JI; Shim YM
Eur J Cardiothorac Surg; 2005 Jun; 27(6):1086-91. PubMed ID: 15896623
[TBL] [Abstract][Full Text] [Related]
56. Pattern of care in adjuvant therapy for resected Stage I non-small cell lung cancer: real-world data from Japan.
Yoh K; Takamochi K; Shukuya T; Hishida T; Tsuboi M; Sakurai H; Goto Y; Yoshida K; Ohde Y; Okumura S; Ohashi Y; Kunitoh H
Jpn J Clin Oncol; 2019 Jan; 49(1):63-68. PubMed ID: 30452719
[TBL] [Abstract][Full Text] [Related]
57. International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer.
Novello S; Torri V; Grohe C; Kurz S; Serke M; Wehler T; Meyer A; Ladage D; Geissler M; Colantonio I; Cauchi C; Stoelben E; Ceribelli A; Kropf-Sanchen C; Valmadre G; Borra G; Schena M; Morabito A; Santo A; Gregorc V; Chiari R; Reck M; Schmid-Bindert G; Folprecht G; Griesinger F; Follador A; Pedrazzoli P; Bearz A; Caffo O; Dickgreber NJ; Irtelli L; Wiest G; Monica V; Porcu L; Manegold C; Scagliotti GV
Ann Oncol; 2022 Jan; 33(1):57-66. PubMed ID: 34624497
[TBL] [Abstract][Full Text] [Related]
58. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
[TBL] [Abstract][Full Text] [Related]
59. Adjuvant chemotherapy for resected non-small-cell lung cancer.
Solomon B; Mitchell JD; Bunn PA
Oncology (Williston Park); 2005 Nov; 19(13):1685-97; discussion 1698-700, 1705. PubMed ID: 16425522
[TBL] [Abstract][Full Text] [Related]
60. Chemotherapy for non-small-cell lung carcinoma: from a blanket approach to individual therapy.
Reungwetwattana T; Eadens MJ; Molina JR
Semin Respir Crit Care Med; 2011 Feb; 32(1):78-93. PubMed ID: 21500127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
